Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.
Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G. Cistaro A, et al. Among authors: borsatti e. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e267-e273. doi: 10.1016/j.clml.2018.04.002. Epub 2018 Apr 14. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29739722
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities.
Antunovic L, Cimitan M, Borsatti E, Baresic T, Sorio R, Giorda G, Steffan A, Balestreri L, Tatta R, Pepe G, Rubello D, Cecchin D, Canzonieri V. Antunovic L, et al. Among authors: borsatti e. Clin Nucl Med. 2012 Aug;37(8):e184-8. doi: 10.1097/RLU.0b013e31825b2583. Clin Nucl Med. 2012. PMID: 22785525
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.
Cimitan M, Evangelista L, Hodolič M, Mariani G, Baseric T, Bodanza V, Saladini G, Volterrani D, Cervino AR, Gregianin M, Puccini G, Guidoccio F, Fettich J, Borsatti E. Cimitan M, et al. Among authors: borsatti e. J Nucl Med. 2015 Feb;56(2):209-15. doi: 10.2967/jnumed.114.141887. Epub 2014 Dec 31. J Nucl Med. 2015. PMID: 25552670 Free article.
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.
Zinzani PL, Broccoli A, Gioia DM, Castagnoli A, Ciccone G, Evangelista A, Santoro A, Ricardi U, Bonfichi M, Brusamolino E, Rossi G, Anastasia A, Zaja F, Vitolo U, Pavone V, Pulsoni A, Rigacci L, Gaidano G, Stelitano C, Salvi F, Rusconi C, Tani M, Freilone R, Pregno P, Borsatti E, Sacchetti GM, Argnani L, Levis A. Zinzani PL, et al. Among authors: borsatti e. J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16. J Clin Oncol. 2016. PMID: 26884559 Free article. Clinical Trial.
FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.
Lopci E, Mascarin M, Piccardo A, Castello A, Elia C, Guerra L, Borsatti E, Sala A, Todesco A, Zucchetta P, Farruggia P, Cistaro A, Buffardi S, Bertolini P, Bianchi M, Moleti ML, Bunkheila F, Indolfi P, Fagioli F, Garaventa A, Burnelli R; AIEOP Hodgkin Lymphoma Study Group, Italy. Lopci E, et al. Among authors: borsatti e. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):97-106. doi: 10.1007/s00259-018-4155-4. Epub 2018 Sep 15. Eur J Nucl Med Mol Imaging. 2019. PMID: 30219963
52 results